| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/08/2001 | WO2001016300A2 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016164A2 Treatment of allergic rhinitis |
| 03/08/2001 | WO2001015745A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | WO2001015744A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/08/2001 | WO2001015733A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 03/08/2001 | WO2001015732A1 Remedies for immunological diseases |
| 03/08/2001 | WO2001015716A1 Plant extract mixtures and their uses |
| 03/08/2001 | WO2001015707A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | WO2001015705A1 Use of fructose-1,6-diphosphate as an inotrope drug for cardiopulmonary bypass surgery |
| 03/08/2001 | WO2001015693A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 03/08/2001 | WO2001015688A1 Ibuprofen-containing softgels |
| 03/08/2001 | WO2001015687A1 Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome |
| 03/08/2001 | WO2001015685A1 Novel uses of sigma receptor agonists |
| 03/08/2001 | WO2001015684A2 Antimycotic drug |
| 03/08/2001 | WO2001015679A2 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders |
| 03/08/2001 | WO2001015678A2 Topical use of kappa opioid agonists to treat otic pain |
| 03/08/2001 | WO2001015677A2 Use of 5-ht1b/1d agonists to treat otic pain |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015674A2 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 03/08/2001 | WO2001015673A2 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 03/08/2001 | WO2001015670A1 Treatment of fungal infections utilizing a fungal growth medium |
| 03/08/2001 | WO2001015664A2 Coformulation methods and their products |
| 03/08/2001 | WO2001015593A2 Compositions for reducing vascular plaque formation and methods of using same |
| 03/08/2001 | WO2001015547A2 Active agent preparation for veterinary use and method for the production thereof |
| 03/08/2001 | WO2000077184A9 Caspase-8 crystals, models and methods |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000057861A3 Use of cytidine derivatives for the treatment of leukaemia |
| 03/08/2001 | WO2000054762A3 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 03/08/2001 | WO2000054760A3 Bicyclo (3.3.1) nonenes useful for the treatment of diabetes and hypertriglyceridemia |
| 03/08/2001 | WO2000050021A3 Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO2000026246A9 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 03/08/2001 | WO2000018961A3 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/08/2001 | WO2000006243A3 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | DE19940227A1 Phospholipidgel Phospholipid |
| 03/08/2001 | CA2391844A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | CA2388036A1 Novel uses of sigma receptor agonists |
| 03/08/2001 | CA2387507A1 Communications system |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | CA2383773A1 Methods and compositions for treating autoimmune disease |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383603A1 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | CA2383601A1 Dna encoding the human serine protease eos |
| 03/08/2001 | CA2383514A1 Screening for agents modulating tgf-beta cell signaling |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382570A1 Treatment of allergic rhinitis |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382556A1 Coformulation methods and their products |
| 03/08/2001 | CA2382551A1 Plant extract mixtures and their uses |
| 03/08/2001 | CA2382427A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | CA2382030A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | CA2381926A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/08/2001 | CA2381895A1 Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome |
| 03/08/2001 | CA2381849A1 Antimycotic drug |
| 03/08/2001 | CA2381813A1 Treatment of fungal infections utilizing a fungal growth medium |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081096A2 Electrolytic reduced water, anti-cancer drug, and producing method and apparatus thereof |
| 03/07/2001 | EP1080730A1 Minoxidil compositions for external use |
| 03/07/2001 | EP1080722A1 Antimycotic compositions |
| 03/07/2001 | EP1080371A1 Method and means for caries prevention and susceptibility detection |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080181A1 clpX OF STREPTOCOCCUS PNEUMONIAE |
| 03/07/2001 | EP1080113A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080055A2 24-hydroxyvitamin d, analogs and uses thereof |
| 03/07/2001 | EP1079875A2 Method and compositions for treatment of cancers |
| 03/07/2001 | EP1079863A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation |
| 03/07/2001 | EP1079855A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA) |
| 03/07/2001 | EP1079853A1 Methods and means for preventing or treating inflammation or pruritis |
| 03/07/2001 | EP1079852A1 Composition based on pentoxifylline and anticytokin |
| 03/07/2001 | EP1079850A1 Compound delivery using rapidly dissolving collagen film |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079847A2 Osteoporosis treatment |
| 03/07/2001 | EP1079844A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1 |
| 03/07/2001 | EP1079843A2 USE OF g(a)1 g(b) INTEGRIN RECEPTOR INHIBITORS AND TGF- g(b)1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 03/07/2001 | EP1079840A1 Synergistic composition of inulin and an anti-cancer drug for use in the treatment of cancer |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | EP1079831A1 Compositions for the treatment of hiv and other viral infections |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/07/2001 | EP1079828A1 New use |
| 03/07/2001 | EP1079818A1 Novel compositions |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079811A1 Biodegradable sustained-release alginate gels |